MRgFUS Destroys Uterine Tumors Noninvasively

The first facility in Arizona to offer a noninvasive procedure for the treatment of a patient's symptomatic uterine tumors is scheduled to open mid October. ExAblate of Phoenix LLC will be available to local gynecologists to perform the nonsurgical treatment of uterine fibroids. The non-invasive procedure uses the ExAblate 2000 system, which received US FDA approval in October 2004.
"The ExAblate technology combines magnetic resonance imaging and focused ultrasound surgery (MRgFUS), which enables us to not only see the fibroid and surrounding organs in 3-D, but to destroy the targeted tumors inside the body without the need for traditional surgical incisions,” said Dr. Robert Gallai, M.D., FRCS(C), FACOG, medical director for ExAblate of Phoenix. “On average, patients return to normal activities in one to two days. Other surgical treatments for fibroids are invasive and can require several days of hospital stay and up to six weeks of recovery time."